SI-BONE to Present at the 37th Annual J.P. Morgan Healthcare Conference
December 20 2018 - 3:05PM
SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is
pioneering the minimally invasive surgical treatment of the
sacroiliac joint with the iFuse Implant System®, today announced
the company will be participating in the upcoming 37th Annual J.P.
Morgan Healthcare Conference in San Francisco, CA.
SI-BONE’s management is scheduled to present on Thursday,
January 10, 2019 at 11:00 a.m. Pacific Time. Interested parties may
access a live and archived webcast of the presentation on the
“Investors” section of the company’s website at:
www.si-bone.com.
About SI-BONE, Inc.SI-BONE is a medical
device company that pioneered the iFuse Implant System, a minimally
invasive surgical system for fusion of the sacroiliac joint to
treat sacroiliac joint dysfunction. The SI joint is believed to be
the last major joint to have a clinically proven surgical
treatment. The iFuse Implant, commercially available since
2009, is believed to be the only SI joint fusion device supported
by multiple prospective clinical studies showing improved pain,
patient function and quality of life resulting from treatment.
There are over 60 peer-reviewed publications supporting the safety,
effectiveness, and biomechanical and economic benefits unique to
the iFuse Implant. This body of evidence has enabled multiple
government and private payors to establish coverage of the SI joint
fusion procedure exclusively when performed with the iFuse Implant
System.The iFuse Implant System is intended for sacroiliac fusion
for conditions including sacroiliac joint dysfunction that is a
direct result of sacroiliac joint disruption and degenerative
sacroiliitis. This includes conditions whose symptoms began during
pregnancy or in the peripartum period and have persisted postpartum
for more than 6 months. There are potential risks associated
with the iFuse Implant System. It may not be appropriate for
all patients and all patients may not benefit.
SI-BONEand iFuse Implant System are registered
trademarks of SI-BONE, Inc. ©2018 SI-BONE,
Inc. All Rights Reserved. 10300.120618
Investor Contact: Lynn
Lewis or Carrie Mendivil investors@SI-BONE.com
Media Contact:Joe Powers
jpowers@si-bone.com
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jun 2024 to Jul 2024
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Jul 2023 to Jul 2024